Contraceptives Market to 2018 – Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen

Publisher Name :
Date: 9-Nov-2012
No. of pages: 85

GBI Research, a leading business intelligence provider, has released its latest research, “Contraceptives Market to 2018 Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen”, which provides insights into the global contraceptives market and market forecasts until 2018. The report provides an in-depth analysis of the most commonly used contraceptives, such as oral, topical, and injectable contraceptives, and devices such as intrauterine devices, condoms, and vaginal rings. The report also examines the usage patterns and annual cost of usage for these segments. It also includes insights into the contraceptives R&D product pipeline and explores the competitive landscape, including major companies in the contraceptives market. Finally, the report also includes analysis of the mergers and acquisitions (M&A) and licensing agreements that have taken place in the global contraceptives market.

The contraceptives market is growing, and more than 90 million people from seven major markets used them in 2011, with more than 24 million people having used them in the US alone. The user population is expected to grow gradually during the forecast period and reach more than 94 million in 2018.

According to GBI Research’s analysis, in 2011, the contraceptives market was worth $10.2 billion, indicating a Compounded Annual Growth Rate (CAGR) of 2.7% between 2004 and 2011. By 2018, the market is expected to reach $11.8 billion, growing at a CAGR of 2.1%. The launch of the FC patch, AG200-15, Savvy Gel, LNG 20, Pill-Plus and some key products in the late stage pipeline combined with increasing awareness are expected to drive the market.

The annual cost of usage for contraceptives was $113 in 2011, which grew from $104 in 2004 at a CAGR of 1.2%. This is expected to grow to $125 in 2018, at a CAGR of 1.4% between 2011 and 2018. The growth rate can be attributed to factors such as the expected patent expiry of Mirena and Yaz. In the forecast period, CSD500, a condom manufactured by Futura Medical and licensed to Reckitt and Benckiser, is expected to strengthen the condom market.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.

Scope

  • Data and analysis on the contraceptives market in leading geographies: the US, the UK, Germany, France, Italy, Spain and Japan; along with their reach in emerging markets.
  • Annualized market data for oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market from 2004-2011, with forecasts to 2018.
  • Market data on the therapeutic landscape, which covers oral, topical and injectable contraceptives, and includes market revenues, treatment usage patterns and the annual cost of usage.
  • Key drivers and restraints that have had a significant impact on the market.
  • The competitive landscape of the contraceptives market, which includes companies such as Bayer, Merck, Church & Dwight, Warner Chilcott Company, and Pfizer.
  • Key M&A activities and licensing agreements that took place from 2008-2012 in the contraceptives market.

Reasons to buy

  • Align your product portfolio to markets with high growth potential.
  • Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
  • Devise a more specifically-tailored country strategy through understanding of the key drivers and barriers in the contraceptives market of all the major countries.
  • Develop key strategic initiatives by understanding the key focus areas of leading companies.
  • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Contraceptives Market to 2018 – Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen

Table of Contents

1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 9

2 Contraceptives Market to 2018 - Introduction 10

3 Contraceptives Market to 2018 - Market Overview 12
3.1 Introduction 12
3.2 Revenue Forecasts for Contraceptives Market 12
3.2.1 Revenues 12
3.2.2 Annual Cost of Usage for Contraceptives 15
3.2.3 Contraceptive Users 16
3.3 Drivers and Barriers for the Contraceptives Market 17
3.3.1 Drivers for Contraceptives Therapeutics Market 17
3.3.2 Barriers for Contraceptives 18

4 Contraceptives Market to 2018 - Geographical Landscape 19
4.1 The US 19
4.1.1 Revenue 19
4.1.2 Annual Cost of Usage for Contraceptives 20
4.1.3 Contraceptive Users 21
4.2 Top Five Countries of Europe 22
4.2.1 Revenue 22
4.2.2 Annual Cost of Usage for Contraceptives 23
4.2.3 Contraceptive Users 24
4.3 Japan 25
4.3.1 Revenue 25
4.3.2 Annual Cost of Usage for Contraceptives 26
4.3.3 Contraceptive Users 27

5 Contraceptives Market to 2018 - Therapeutic Landscape 28
5.1 Oral Contraceptives 28
5.1.1 Introduction 28
5.1.2 Combined Hormonal Contraception 29
5.1.3 Oral Contraceptive Historic Trends 29
5.1.4 Recently Approved Combined Oral Contraceptives 29
5.1.5 Revenue 30
5.1.6 Annual Cost of Usage 33
5.1.7 Oral Contraceptive Users 34
5.2 Injectables 35
5.2.1 Introduction 35
5.2.2 Revenue 35
5.2.3 Annual Cost of Usage 39
5.2.4 Injectable Contraceptive Users 40
5.3 Topical Contraceptives 41
5.3.1 Introduction 41
5.3.2 Revenue 42
5.3.3 Annual Cost of Usage 45
5.3.4 Topical Contraceptive Users 46

6 Contraceptives Market to 2018 - Devices Landscape 47
6.1 Vaginal Ring 47
6.1.1 Introduction 47
6.1.2 Revenue 47
6.1.3 Geographical Segmentation 49
6.1.4 Annual Cost of Usage 51
6.1.5 Vaginal Ring Users 52
6.2 Intrauterine Device 53
6.2.1 Introduction 53
6.2.2 Revenue 53
6.2.3 Geographical Segmentation 55
6.2.4 Annual Cost of Usage 57
6.2.5 IUDs Users 58
6.3 Condoms 59
6.3.1 Introduction 59
6.3.2 Revenue 59
6.3.3 Geographical Segmentation 60
6.3.4 Annual Cost of Usage 62
6.3.5 Condom Users 63

7 Emerging Markets 64
7.1 China 64
7.2 Australia 65
7.3 India 66

8 Contraceptives Market to 2018 - Pipeline Analysis 67
8.1 Introduction 67
8.2 Profiles of Promising Drugs in the Global Contraceptives Market 68
8.2.1 AG200-15 68
8.2.2 FC Patch Low 68
8.2.3 Pill-Plus 69

9 Contraceptives Market to 2018 - Competitive Landscape 70
9.1 Market Share Analysis - Contraceptives Market 70
9.2 Drug Profile of Major Marketed Contraceptives 71
9.2.1 Yaz/Yasmin 71
9.2.2 Mirena 71
9.2.3 Nuvaring 71
9.3 Competitive Profiling 72
9.3.1 Bayer 72
9.3.2 Merck 73
9.3.3 Church & Dwight 74
9.3.4 Warner Chilcott Company, Inc. 75
9.3.5 Pfizer Inc. 76

10 Contraceptives Market to 2018 - Strategic Consolidations 77
10.1 Mergers and Acquisitions 77
10.1.1 Major M&A Deals 77
10.1.2 Licensing Agreements 77
10.1.3 Deals by Geography 78
10.1.4 Major Licensing Agreements 78
10.1.5 Co-development 79

11 Contraceptives Market to 2018 - Appendix 80
11.1 Market Definitions 80
11.2 Abbreviations 80
11.3 Bibliography 80
11.4 Research Methodology 81
11.4.1 Coverage 82
11.4.2 Secondary Research 82
11.4.3 Primary Research 82
11.4.4 Expert Panel Validation 83
11.5 Therapeutic Landscape 83
11.5.1 Epidemiology-Based Forecasting 83
11.5.2 Market Size by Geography 84
11.6 Geographical Landscape 84
11.7 Pipeline Analysis 84
11.8 Competitive Landscape 84
11.9 Contact Us 85
11.10 Disclaimer 85

List of Tables

Table 1: Contraceptives Market, Global, Revenue ($bn), 2004-2011 12
Table 2: Contraceptives Market, Global, Revenue Forecasts ($bn), 2011-2018 12
Table 3: Contraceptives Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 13
Table 4: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 14
Table 5: Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2011 15
Table 6: Contraceptives Market, Global, Annual Cost of Usage ($), 2011-2018 15
Table 7: Contraceptives Market, Global, Contraceptive Users (Million), 2004-2011 16
Table 8: Contraceptives Market, Global, Contraceptive Users (Million), 2011-2018 16
Table 9: Contraceptives Market, The US, Revenue ($bn), 2004-2011 19
Table 10: Contraceptives Market, The US, Revenue Forecasts ($bn), 2011-2018 19
Table 11: Contraceptives Market, The US, Annual Cost of Usage ($), 2004-2011 20
Table 12: Contraceptives Market, The US, Annual Cost of Usage ($), 2011-2018 20
Table 13: Contraceptives Market, The US, Contraceptive Users (Million), 2004-2011 21
Table 14: Contraceptives Market, The US, Contraceptive Users (Million), 2011-2018 21
Table 15: Contraceptives Market, Top Five Countries of Europe, Revenue ($m), 2004-2011 22
Table 16: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts ($m), 2011-2018 22
Table 17: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage ($), 2004-2011 23
Table 18: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage ($), 2011-2018 23
Table 19: Contraceptives Market, Top Five Countries of Europe, Contraceptive Users (Million), 2004-2011 24
Table 20: Contraceptives Market, Top Five Countries of Europe, Contraceptive Users (Million), 2011-2018 24
Table 21: Contraceptives Market, Japan, Revenue ($m), 2004-2011 25
Table 22: Contraceptives Market, Japan, Revenue Forecasts ($m), 2011-2018 25
Table 23: Contraceptives Market, Japan, Annual Cost of Usage ($), 2004-2011 26
Table 24: Contraceptives Market, Japan, Annual Cost of Usage ($), 2011-2018 26
Table 25: Contraceptives Market, Japan, Contraceptive Users (Million), 2004-2011 27
Table 26: Contraceptives Market, Japan, Contraceptive Users (Million), 2011-2018 27
Table 27: Oral Contraceptives Market, Global, Revenue ($bn), 2004-2011 30
Table 28: Oral Contraceptives Market, Global, Revenue Forecasts ($bn), 2011-2018 30
Table 29: Oral Contraceptives Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 31
Table 30: Oral Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 32
Table 31: Oral Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2011 33
Table 32: Oral Contraceptives Market, Global, Annual Cost of Usage ($), 2011-2018 33
Table 33: Oral Contraceptives Market, Global, Users (Million), 2004-2011 34
Table 34: Oral Contraceptives Market, Global, Users (Million), 2011-2018 34
Table 35: Injectables Market, Global, Revenue ($m), 2004-2011 36
Table 36: Injectables Market, Global, Revenue Forecasts ($m), 2011-2018 36
Table 37: Injectables Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 37
Table 38: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 38
Table 39: Injectables Market, Global, Annual Cost of Usage ($), 2004-2011 39
Table 40: Injectables Market, Global, Annual Cost of Usage ($), 2011-2018 39
Table 41: Injectable Contraceptives Market, Global, Users (‘000), 2004-2011 40
Table 42: Injectable Contraceptives Market, Global, Users (‘000), 2011-2018 40
Table 43: Topical Contraceptives Market, Global, Revenue ($m), 2004-2011 42
Table 44: Topical Contraceptives Market, Global, Revenue Forecasts ($m), 2011-2018 42
Table 45: Topical Contraceptives Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 43
Table 46: Topical Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 44
Table 47: Topical Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2011 45
Table 48: Topical Contraceptives Market, Global, Annual Cost of Usage ($), 2011-2018 45
Table 49: Topical Contraceptives Market, Global, Users (Million), 2004-2011 46
Table 50: Topical Contraceptives Market, Global, Users (Million), 2011-2018 46
Table 51: Vaginal Ring Market, Global, Revenue ($m), 2004-2011 48
Table 52: Vaginal Ring Market, Global, Revenue Forecasts ($m), 2011-2018 48
Table 53: Vaginal Ring Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 49
Table 54: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 50
Table 55: Vaginal Ring Market, Global, Annual Cost of Usage ($), 2004-2011 51
Table 56: Vaginal Ring Market, Global, Annual Cost of Usage ($), 2011-2018 51
Table 57: Vaginal Ring Market, Global, Users ('000), 2004-2011 52
Table 58: Vaginal Ring Market, Global, Users (‘000), 2011-2018 52
Table 59: Intrauterine Devices Market, Global, Revenue ($m), 2004-2011 54
Table 60: Intrauterine Device Market, Global, Revenue Forecasts ($m), 2011-2018 54
Table 61: IUDs Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 55
Table 62: IUDs Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 56
Table 63: IUDs Market, Global, Annual Cost of Usage ($), 2004-2011 57
Table 64: IUDs Market, Global, Annual Cost of Usage ($), 2011-2018 57
Table 65: IUDs Market, Global, Users (Million), 2004-2011 58
Table 66: IUDs Market, Global, Users (Million), 2011-2018 58
Table 67: Condoms Market, Global, Revenue ($bn), 2004-2011 59
Table 68: Condoms Market, Global, Revenue Forecasts ($bn), 2011-2018 59
Table 69: Condoms Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 60
Table 70: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2011-2018 61
Table 71: Condoms Market, Global, Annual Cost of Usage ($), 2004-2011 62
Table 72: Condoms Market, Global, Annual Cost of Usage ($), 2011-2018 62
Table 73: Condom Market, Global, Users (Million), 2004-2011 63
Table 74: Condom Market, Global, Users (Million), 2011-2018 63
Table 75: Contraceptives Market, Method of Contraceptive Used (%), China 64
Table 76: Contraceptives Market, Method of Contraceptive Used (%), Australia 65
Table 77: Contraceptives Market, Method of Contraceptive Usage (%), India 66
Table 78: Contraceptives Market, Global, Product Pipeline by Phase, 2012 67
Table 79: Contraceptives Market, Global, Revenues of Major Marketed Contraceptives ($m), 2011 71

List of Figures

Figure 1: Contraceptives Market, Global, Revenue Forecasts ($bn), 2004-2018 12
Figure 2: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 13
Figure 3: Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2018 15
Figure 4: Contraceptives Market, Global, Contraceptive Users (Million), 2004-2018 16
Figure 5: Contraceptives Market, Global, Drivers and Barriers, 2011 17
Figure 6: Contraceptives Market, The US, Revenue Forecasts ($bn), 2004-2018 19
Figure 7: Contraceptives Market, The US, Annual Cost of Usage ($), 2004-2018 20
Figure 8: Contraceptives Market, The US, Contraceptive Users (Million), 2004-2018 21
Figure 9: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts ($m), 2004-2018 22
Figure 10: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage ($), 2004-2018 23
Figure 11: Contraceptives Market, Top Five Countries of Europe, Contraceptive Users (Million), 2004-2018 24
Figure 12: Contraceptives Market, Japan, Revenue Forecasts ($m), 2004-2018 25
Figure 13: Contraceptives Market, Japan, Annual Cost of Usage ($), 2004-2018 26
Figure 14: Contraceptives Market, Japan, Contraceptive Users (Million), 2004-2018 27
Figure 15: Oral Contraceptives Market, Global, Revenue Forecasts ($bn), 2004-2018 30
Figure 16: Oral Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 31
Figure 17: Oral Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2018 33
Figure 18: Oral Contraceptives Market, Global, Users (Million), 2004-2018 34
Figure 19: Injectables Market, Global, Revenue Forecasts ($m), 2004-2018 35
Figure 20: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 37
Figure 21: Injectables Market, Global, Annual Cost of Usage ($), 2004-2018 39
Figure 22: Injectable Contraceptives Market, Global, Users (‘000), 2004-2018 40
Figure 23: Topical Contraceptives Market, Global, Revenue Forecasts ($m), 2004-2018 42
Figure 24: Topical Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 43
Figure 25: Topical Contraceptives Market, Global, Annual Cost of Usage ($), 2004-2018 45
Figure 26: Topical Contraceptives Market, Global, Users (Million), 2004-2018 46
Figure 27: Vaginal Ring Market, Global, Revenue Forecasts ($m), 2004-2018 47
Figure 28: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 49
Figure 29: Vaginal Ring Market, Global, Annual Cost of Usage ($), 2004-2018 51
Figure 30: Vaginal Ring Market, Global, Users (‘000), 2004-2018 52
Figure 31: Intrauterine Devices Market, Global, Revenue Forecasts ($m), 2004-2018 53
Figure 32: IUDs Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 55
Figure 33: IUDs Market, Global, Annual Cost of Usage ($), 2004-2018 57
Figure 34: IUDs Market, Global, Users (Million), 2004-2018 58
Figure 35: Condoms Market, Global, Revenue Forecasts ($bn), 2004-2018 59
Figure 36: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation ($m), 2004-2018 60
Figure 37: Condoms Market, Global, Annual Cost of Usage ($), 2004-2018 62
Figure 38: Condom Market, Global, Users (Million), 2004-2018 63
Figure 39: Contraceptives Market, Global, Product Pipeline by Phase, (%), 2011 67
Figure 40: Contraceptives Market, Global, Market Share Analysis, (%), 2011 70
Figure 41: Contraceptives Market, Global, Bayer, SWOT Analysis, 2011 72
Figure 42: Contraceptives Market, Global, Merck, SWOT Analysis, 2011 73
Figure 43: Contraceptives Market, Global, Church & Dwight, SWOT Analysis, 2011 74
Figure 44: Contraceptives Market, Global, Warner Chilcott Company, Inc., SWOT Analysis, 2011 75
Figure 45: Contraceptives Market, Global, Pfizer Inc., SWOT Analysis, 2011 76
Figure 46: Contraceptives Market, Global, Licensing Agreements by Geography, 2011 78

  • Changing Faces of the Refining Industry
    The Refining Industry is one of the most profitable industries in the world. The industry deals with the production of gasoline, kerosene, distillate fuel oils, residual fuel oils, and lubricants, through fractionation or straight distillation of crude oil, redistillation of unfinished petroleum derivatives, cracking or other processes. One of the most important factors of this [...]
  • Chinese Vacuum Pumps Industry to Grow at a CAGR of 5.5% to 2018
    A vacuum pump is used in most of the activities we do in our every day life. Some of its regular application are air conditioning, automobiles, CDs andDVDs, television tubes, etc. It is also used in hi-tech companies for creating process like coating of microchips and also manufacturing of optical glass or analytical instruments. The [...]
  • Overcoming Obesity
    In today’s world where there are countries struggling to overcome famine and shortage of food there are others who are increasingly getting populated with obese people. Obesity is one of the key problem many are facing across the world. It is a result of either improper lifestyle and food habits or is completely hereditary. In [...]
  • The Booming Market of Carbon Fibre
    The speed at which the Carbon Fibre Industry is growing it is sure to be one of the most profitable industry in the years to come. The sales of carbon fibre tow is expected to increase from $1.6 billion in 2011 to $4.5 billion in 2020. The overall The global demand for carbon fibre tow [...]
  • Incentivising Research & Development Activities
    Research and Development (R&D) is the base of innovation, competitiveness and economic performance. Any company or a country that seeks to be ahead of its competitors need to invest heavily in setting up an active R&D wing. In today’s world everything is technology oriented.  People are coming up with new ideas, products and newer ways [...]
  • The Boom In Women Infertility Market
  • Infertility is an abnormality in the regular functioning of the human reproductive system. Anyone of male or female might be suffering from this issue. Infertility in woman is caused by either a genetical factor or factors such as aging or …

  • Retaining the Hard-Won Consumers
  • With the increase in mobile phone usage different operators are coming up with different plan in order to cater to users of all age-group with various data plan to choose from. With the maturing mobile market operators are coming up …

  • To bring in Photography to the Real World Visual Supply Co Acquires Artifact Uprising
  • Visual Supply Co, VSCO has brought a Denver-based startup, Artifact Uprising, which is focused on bringing photographers’ work from the digital hubs on regular basis by modern creatives to the real world as prints and tangible books. Artifact Uprising is …

  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Latvia Pharmaceuticals and Healthcare Report Q2 2015
    Published: 1-Apr-2015        Price: US $1295 Onwards        Pages: 103
    BMI View: Market growth forecasts are strong although the country will continue to present a modest opportunity to larger multinational companies on account of its relatively small market size. Meanwhile, tensions between Ukraine and Russia may provide challenges for local manufacturers that had sought exports to Russia and the Commonwealth of Independent States (CIS) region as a remedy for lacklustre domestic demand in recent years. Headline Expenditure Projections ? Pharmaceuticals: EUR340mn (......
  • Zambia Pharmaceuticals and Healthcare Report Q2 2015
    Published: 1-Apr-2015        Price: US $1295 Onwards        Pages: 63
    BMI View: The newly-elected government has already made some healthcare promises to the people of Zambia, such as its pledge to ensure the creation of 650 health clinics. However, there remains much political and economic uncertainty in the country, with President Edgar Lungu having only recently been elected and facing an economic crisis following the fall in copper prices since the start of the year. Improving healthcare provision and mortality statistics are therefore unlikely to be the gover......
  • Global Biobanking Market 2015-2019
    Published: 1-Apr-2015        Price: US $2500 Onwards        Pages: 80
    Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA. The human biobanks work by systematic collection of biological samples from patients and other members of the public. Biobanks significantly vary in size such as biobanks held in medical institutions hold relatively modest num......
  • Global Healthcare BPO Market 2015-2019
    Published: 1-Apr-2015        Price: US $3000 Onwards        Pages: 117
    BPO is a segment of outsourcing, which consists of subcontracting the business processes of an organization to a third-party vendor that has the expertise in the required domains. It helps clients to increase their operational efficiency, concentrate on their core competencies, reduce time-to-market, obtain access to fresh talent and experience along with the latest technologies, and build an organization with an economical cost structure in the long run. The healthcare space has been witnessing......
  • Austria Pharmaceuticals and Healthcare Report Q2 2015
    Published: 1-Apr-2015        Price: US $1295 Onwards        Pages: 71
    BMI View: The Austrian pharmaceutical and healthcare sectors are well developed and stable, offering some of the most attractive opportunities in the region. Our updated forecasts indicate a continuing moderate rebound in both pharmaceutical and healthcare expenditure in 2015 in local currency terms as opposed to weak numbers achieved in 2013 This is encouraging given the fact that the market will continue to be affected by the drug pricing restrictions and public spending cuts. Headline Expendi......
  • Botswana Pharmaceuticals and Healthcare Report Q2 2015
    Published: 1-Apr-2015        Price: US $1295 Onwards        Pages: 66
    BMI View: With Botswana's plans to manufacture drugs locally stalling, the country will remain reliant on importing its pharmaceutical needs for the foreseeable future. The government's commitment to healthcare sector development will continue driving import growth to outperform exports. Botswana makes an attractive manufacturing destination, though its small market size is a deterrent to investment. Headline Expenditure Projections ? Pharmaceuticals: BWP1.82bn (USD203mn) in 2014 to BWP1.99bn (U......
  • Brazil Pharmaceuticals and Healthcare Report Q2 2015
    Published: 1-Apr-2015        Price: US $1295 Onwards        Pages: 144
    BMI View: Continued regulatory improvements, growing pharmaceutical and healthcare markets, and increased favour for foreign investment will allow Brazil to maintain its position as the regional outperformer in Latin America. However, low affordability and increasing generic drug competition will hamper opportunities for innovative drugmakers as the country continues to develop its economy. Headline Expenditure Projections Pharmaceuticals: BRL62.0bn (USD26.3bn) in 2014 to BRL65.3bn (USD25.6bn) i......
  • China Pharmaceuticals and Healthcare Report Q2 2015
    Published: 1-Apr-2015        Price: US $1295 Onwards        Pages: 198
    BMI View: Pharmaceutical sales in China will continue to grow robustly - boosted by the improvement in healthcare access, liberalisation of the industry as well as an epidemiological transition towards chronic diseases. This will present strong revenue earning opportunities for both domestic and multinational pharmaceutical companies. However, downside risks to this upbeat outlook remain as the government will face pressures to contain medicine costs. Headline Expenditure Projections ? Pharmaceu......
  • Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) – Global Forecast to 2019
    Published: 26-Mar-2015        Price: US $4650 Onwards        Pages: 210
    The global pharmacovigilance and drug safety software market is expected to grow at a CAGR of 6.5% from 2014 to 2019. North America region held the largest share of the pharmacovigilance and drug safety software market in 2014. However, Asian and Latin American countries symbolize high growth markets. This is owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations. The growth of the global ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs